Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. GlaxoSmithKline Pharmaceuticals Limited
  6. News
  7. Summary
    500660   INE159A01016

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

(500660)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

GlaxoSmithKline Pharmaceuticals' : Consolidated Net Profit Climbs in Fiscal Q1

07/26/2021 | 11:28pm EST


ę MT Newswires 2021
All news about GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
01/23India's HDFC Capital raises $1.8 billion from ADIA, others for low-cost housing
RE
2021GlaxoSmithKline Pharmaceuticals Completes Sale of Karnataka Manufacturing Business in I..
MT
2021Hetero Labs Limited completed the acquisition of Manufacturing Facility at Vemgal from ..
CI
2021GlaxoSmithKline Pharmaceuticals' Consolidated Net Profit Nearly Triples in Fiscal Q2
MT
2021GSK delivers 13% sales growth for the quarter ended September 30, 2021 Innovation and S..
AQ
2021GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Second Quarter..
CI
2021GLAXOSMITHKLINE PHARMACEUTICALS' : Consolidated Net Profit Climbs in Fiscal Q1
MT
2021Glaxosmithkline Pharmaceuticals Limited Reports Earnings Results for the First Quarter ..
CI
2021GLAXOSMITHKLINE PHARMACEUTICALS LIMI : Ex-dividend day for final dividend
FA
2021Sanofi, GSK get Indian approval for late-stage trial of COVID-19 vaccine
RE
More news
Financials
Sales 2022 36 404 M 488 M 488 M
Net income 2022 6 445 M 86,4 M 86,4 M
Net cash 2022 12 388 M 166 M 166 M
P/E ratio 2022 44,4x
Yield 2022 2,56%
Capitalization 284 B 3 827 M 3 812 M
EV / Sales 2022 7,47x
EV / Sales 2023 7,01x
Nbr of Employees 4 283
Free-Float -
Chart GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Duration : Period :
GlaxoSmithKline Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 1 725,50 INR
Average target price 1 651,29 INR
Spread / Average Target -4,30%
EPS Revisions
Managers and Directors
Sridhar Venkatesh Managing Director & Director
Puja Thakur Chief Financial Officer & Executive Director
Renu Sud Karnad Non-Executive Chairman
Priyanka Bhatia Head-Medical Affairs
Ajay A. Nadkarni Secretary & Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-1.99%3 933
JOHNSON & JOHNSON-3.62%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-12.00%220 356